BPSR

Organicell Regenerative Medicine, Inc. [BPSR] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

BPSR Stock Summary

In the News

BPSR Financial details

Company Rating
-
Market Cap
0
Income
-16.96M
Revenue
4.91M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
18
Optionable
No
Shortable
Yes
Earnings
-
P/E
-3.2
Forward P/E
-
PEG
-0.17
P/S
-
P/B
-28.92
P/C
-
P/FCF
-
Quick Ratio
0.24
Current Ratio
0.33
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.02
EPS next Y
-
EPS next Q
-
EPS this Y
193.75%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
8.5%
Revenue last 5Y
75.25%
Revenue Q/Q
14.46%
EPS Q/Q
-38.1%
-
-
-
-
SMA20
-
SMA50
-33.33%
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-943%
ROE
852%
ROC
10.32%
Gross Margin
87%
Oper. Margin
-407%
Profit Margin
-412%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.045-0.06
52W High
-
52W Low
-
RSI
37.47
Rel Volume
1.65
Avg Volume
1.58M
Volume
2.62M
Perf Week
-16.42%
Perf Month
-36.36%
Perf Quarter
-
Perf Half Y
-56.52%
-
-
-
-
Beta
7.13974
-
-
Volatility
0%, 0%
Prev Close
-10.83%
Price
0.014
Change
-11.17%

Something similar

Top by Market Cap
NVDA
CMC.DE
JPM
ABEA.DE
BRYN.DE
Same Sector
603127.SS
ULTI.OL
HOLX
ODT
DSKYF
Check Those
ODC
CHPMW
LLD.DE
FLXE
WTMAR
Similar Market Cap
PBPB
TAMVX
ETAC
LABB.MX
GAPB.MX

Company Profile

Healthcare Biotechnology
  • Volume Average 1.58M
  • Employee 18
  • CEO Mr. Albert Mitrani
  • Headquarters Miami,FL,US
  • IPO Date 2022-01-31
  • Website http://www.organicell.com

Organicell Regenerative Medicine, Inc. processes, distributes, and supplies biologically processed cellular and tissue-based products in the United States. The company was formerly known as Biotech Products Services and Research, Inc. and changed its name to Organicell Regenerative Medicine, Inc. in June 2018. Organicell Regenerative Medicine, Inc. has an agreement with Regenerative Care Network to study potential therapeutic benefits of Zofin for patients with heart failure. Organicell Regenerative Medicine, Inc. was founded in 2011 and is headquartered in Miami, Florida.